CVSS 3.1
9.8 criticalCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:HCVE-2021-43935
Critical (9.8) in baxter. EPSS 1.1% chance of exploitation in the next 30 days.
The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.
Severity
- EPSS
- 1.1% chance of exploitation in the next 30 days; higher than 66% of CVEs (scores of 2026-10-31)
- CWEs
- CWE-287, CWE-288
- Published
- Modified
- Record from
- the NVD, synced
Affected
- baxter:welch_allyn_connex_cardio
- baxter:welch_allyn_diagnostic_cardiology_suite
- baxter:welch_allyn_hscribe_holter_analysis_system_firmware
- baxter:welch_allyn_q-stress_cardiac_stress_testing_system_firmware
- baxter:welch_allyn_rscribe_resting_ecg_system
- baxter:welch_allyn_vision_express_holter_analysis_system
- baxter:welch_allyn_xscribe_cardiac_stress_testing_system_firmware